Navigation Links
Jarrow Formulas Launches New Products Featuring BioCell Collagen II(R)
Date:10/4/2007

The two new products, Skin Optimizer and Hyaluronic Acid Complex, promote

skin and joint health benefits.

ANAHEIM, Calif., Oct. 4 /PRNewswire/ -- Jarrow Formulas, recognized in July by Nutrition Business Journal, selected BioCell Collagen II -- a patented and clinically supported natural ingredient to enhance the effectiveness of two new Jarrow Formulas products -- Skin Optimizer and Hyaluronic Acid Complex. The new formulations featuring BioCell Collagen II supply a naturally occurring matrix of bioavailable hydrolyzed collagen type II, hyaluronic acid (HA) and chondroitin sulfate (CS), and is made in the United States under strict quality control guidelines. As components of cartilage, this natural form is essential in promoting cartilage growth and the appearance of youthful skin.

"Jarrow Formulas joins the elite class of reputable companies that use BioCell Collagen II in their formulas," said Suhail Ishaq, vice president of BioCell Technology, LLC. "Once again, consumers can feel assured that they are receiving only the highest quality ingredients that they would expect from an industry leader such as Jarrow Formulas."

Jarrow Formulas Skin Optimizer is an advanced skin care formula with BioCell Collagen II and other highly effective supporting nutrients that have been shown clinically to enhance skin integrity.

Jarrow Formulas Hyaluronic Acid Complex provides the fluid matrix for joint lubrication, skin hydration, and skin repair. Unlike ordinary collagen products, patented BioCell Collagen II is a rich source of bioavailable hyaluronic acid and is clinically proven to support joint health. Each capsule provides 50mg of bioavailable hyaluronic acid.

Jarrow Formulas, Inc. is a nutritional supplement formulator and marketer founded in 1977 and incorporated in 1988. Jarrow Formulas, Inc. is active in regulatory affairs, helping to maintain Americans' rights to free access to dietary supplements. For more information, contact Mark Becker, director, advertising/communications, toll-free at (800) 726-0886 or access the Jarrow Formulas Web site at http://www.Jarrow.com.

Founded in 1997, BioCell Technology, LLC owns the exclusive rights to license BioCell Collagen II under the United States Patents #6,025,327, 6,323,319, 6,780,841, other U.S. and foreign patents pending. BioCell Collagen II is a branded dietary ingredient that is available to dietary supplement and functional foods manufacturers to market under their own brand name or formulas. For more information on BioCell Collagen II, contact Suhail Ishaq at BioCell Technology, LLC at (714) 632-1231, or visit http://www.biocelltechnology.com.


'/>"/>
SOURCE BioCell Technology, LLC
Copyright©2007 PR Newswire.
All rights reserved

Related biology technology :

1. Merge launches diagnostic mammography workstation in Europe
2. Einstein Wireless launches cellular alert system
3. Logistics Health launches compliance management tool
4. UW-Madison launches new high-speed research network
5. UWM launches research foundation
6. TeraMedica launches information manager
7. GE Healthcare launches hybrid electronic record
8. Cedara launches new version of DICOM toolkit
9. Merge launches Spanish version of imaging tool
10. Doyle launches 2025 alternative energy plan
11. Jellyfish launches comparative shopping website
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... ... June 27, 2016 , ... Parallel 6 , the leading software as ... Clinical Reach Virtual Patient Encounter CONSULT module which enables both audio and video ... trial team. , Using the CONSULT module, patients and physicians can schedule a face ...
(Date:6/27/2016)... --  Ginkgo Bioworks , a leading organism design ... awarded as one of the World Economic Forum,s ... innovative companies. Ginkgo Bioworks is engineering biology to ... in the nutrition, health and consumer goods sectors. ... including Fortune 500 companies to design microbes for ...
(Date:6/24/2016)... ... , ... Researchers at the Universita Politecnica delle Marche in Ancona combed medical ... mesothelioma. Their findings are the subject of a new article on the Surviving Mesothelioma ... in the blood, lung fluid or tissue of mesothelioma patients that can help point ...
(Date:6/23/2016)... , June 23, 2016 /PRNewswire/ - FACIT ... Ontario biotechnology company, Propellon Therapeutics ... development and commercialization of a portfolio of first-in-class ... Epigenetic targets such as WDR5 represent an exciting ... significantly in precision medicine for cancer patients. Substantial ...
Breaking Biology Technology:
(Date:5/16/2016)... , May 16, 2016   EyeLock LLC ... today announced the opening of an IoT Center of ... strengthen and expand the development of embedded iris biometric ... unprecedented level of convenience and security with unmatched biometric ... one,s identity aside from DNA. EyeLock,s platform uses video ...
(Date:4/28/2016)... First quarter 2016:   , Revenues amounted ... quarter of 2015 The gross margin was 49% (27) ... the operating margin was 40% (-13) Earnings per share ... operations was SEK 249.9 M (21.2) , Outlook   ... M. The operating margin for 2016 is estimated to ...
(Date:4/15/2016)... 2016 Research and Markets has ... Market 2016-2020,"  report to their offering.  , ... ,The global gait biometrics market is expected to ... period 2016-2020. Gait analysis generates multiple ... used to compute factors that are not or ...
Breaking Biology News(10 mins):